{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T16:49:53Z","timestamp":1784825393645,"version":"3.55.0"},"reference-count":82,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Glucocorticoid-induced osteoporosis (GIO) poses a significant risk to pediatric patients undergoing chronic glucocorticoid therapy for inflammatory, autoimmune, and genetic conditions. This review highlights the pathophysiology of GIO in children and emerging insights into the role of bone vasculature in skeletal health during growth.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>GIO arises from a dual mechanism of increased bone resorption and decreased bone formation, leading to rapid declines in bone mineral density. Recent studies emphasize the importance of angiogenic-osteogenic coupling, particularly in the growing skeleton. Endothelial cells are now recognized as active participants in bone health and regeneration. Advances in the understanding of signaling pathways regulating skeletal angiogenesis could predict skeletal side effects during drug development. Therapies enhancing endothelial cell function or promoting skeletal angiogenesis could mitigate glucocorticoid-induced damage. Key signaling pathways, such as platelet-derived growth factor type BB and nuclear factor (NF)-\u03baB play critical roles in recruiting osteoprogenitors and establishing a vascular niche for skeletal angiogenesis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>GIO is uniquely concerning in children due to its impact on peak bone mass and lifelong fracture risk. Understanding how glucocorticoids impair bone vasculature and skeletal remodeling may reveal new therapeutic targets to preserve bone health and mitigate the osteotoxic effects of long-term glucocorticoid use in the growing skeleton.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000001476","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T21:00:06Z","timestamp":1748552406000},"page":"390-397","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Glucocorticoid-induced osteoporosis in children: emerging vascular and molecular targets"],"prefix":"10.1097","volume":"37","author":[{"given":"Sisir Kumar","family":"Barik","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics"},{"name":"The Center for Musculoskeletal Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet L.","family":"Crane","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics"},{"name":"Department of Orthopedic Surgery"},{"name":"The Center for Musculoskeletal Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"R1-20250819","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s40267-024-01079-4","article-title":"Glucocorticoid-induced osteoporosis\u2014from molecular mechanism to clinical practice","volume":"40","author":"Hsu","year":"2024","journal-title":"Drugs TherPerspect"},{"key":"R2-20250819","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2018.05.025","article-title":"Preservation of type H vessels and osteoblasts by enhanced preosteoclast platelet-derived growth factor type BB attenuates glucocorticoid-induced osteoporosis in growing mice","volume":"114","author":"Yang","year":"2018","journal-title":"Bone"},{"key":"R3-20250819","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.semarthrit.2014.02.002","article-title":"A systematic review and meta-analysis of glucocorticoid-induced osteoporosis in children","volume":"44","author":"Hansen","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"R4-20250819","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.00576","article-title":"Glucocorticoid-induced osteoporosis: why kids are different","volume":"11","author":"Ward","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R5-20250819","doi-asserted-by":"crossref","first-page":"37","DOI":"10.14238\/pi62.1.2022.37-43","article-title":"Linear growth and systemic glucocorticoid therapy in children with systemic lupus erythematosus","volume":"62","author":"Anugrah","year":"2022","journal-title":"Paediatrica Indonesiana"},{"key":"R6-20250819","doi-asserted-by":"crossref","first-page":"97","DOI":"10.5152\/eurjrheum.2023.22086","article-title":"Glucocorticoid-induced osteoporosis: increased awareness as a management strategy for prevention of this complication in patients with systemic autoimmune rheumatic disease","volume":"10","author":"Bankole","year":"2023","journal-title":"Eur J Rheumatol"},{"key":"R7-20250819","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1056\/NEJMcp1800214","article-title":"Glucocorticoid-induced osteoporosis","volume":"379","author":"Lenore","year":"2018","journal-title":"N Engl J Med"},{"key":"R8-20250819","doi-asserted-by":"crossref","DOI":"10.1186\/s12969-018-0258-5","article-title":"Early use of alendronate as a protective factor against the development of glucocorticoid-induced bone loss in childhood-onset rheumatic diseases: a cross-sectional study","volume":"16","author":"Inoue","year":"2018","journal-title":"Pediatr Rheumatol"},{"key":"R9-20250819","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.18203\/2349-3291.ijcp20201638","article-title":"Urinary calcium and bone mineral density in children with nephrotic syndrome treated with glucocorticoids","volume":"7","author":"Patil","year":"2020","journal-title":"Int J Contemp Pediatr"},{"key":"R10-20250819","doi-asserted-by":"crossref","DOI":"10.1186\/1546-0096-12-24","article-title":"A survey of steroid-related osteoporosis diagnosis, prevention and treatment practices of pediatric rheumatologists in North America","volume":"12","author":"Soybilgic","year":"2014","journal-title":"Pediatr Rheumatol"},{"key":"R11-20250819","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/MED.0000000000000368","article-title":"Advances in treatment of glucocorticoid-induced osteoporosis","volume":"24","author":"Hsu","year":"2017","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"R12-20250819","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1210\/clinem\/dgae507","article-title":"Approach to the pediatric patient with glucocorticoid-induced osteoporosis","volume":"110","author":"Ward","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"R13-20250819","doi-asserted-by":"crossref","DOI":"10.1038\/s41413-022-00219-8","article-title":"Bone remodeling: an operational process ensuring survival and bone mechanical competence","volume":"10","author":"Bolamperti","year":"2022","journal-title":"Bone Res"},{"key":"R14-20250819","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2015.00041","article-title":"Coupling signals between the osteoclast and osteoblast: How are messages transmitted between these temporary visitors to the bone surface?","volume":"6","author":"Sims","year":"2015","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R15-20250819","doi-asserted-by":"crossref","DOI":"10.1186\/ar2165","article-title":"Biology of RANK, RANKL, and osteoprotegerin","volume":"9","author":"Boyce","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"R16-20250819","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2022.116540","article-title":"Cytokine-mediated immunomodulation of osteoclastogenesis","volume":"164","author":"Zhou","year":"2022","journal-title":"Bone"},{"key":"R17-20250819","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.3892\/mmr.2015.3152","article-title":"Receptor activator of nuclear factor-\u03baB ligand (RANKL)\/RANK\/osteoprotegerin system in bone and other tissues (Review)","volume":"11","author":"Liu","year":"2015","journal-title":"Mol Med Rep"},{"key":"R18-20250819","doi-asserted-by":"crossref","DOI":"10.1038\/s41413-018-0019-6","article-title":"Paracrine and endocrine actions of bone \u2013 the functions of secretory proteins from osteoblasts, osteocytes, and osteoclasts","volume":"6","author":"Han","year":"2018","journal-title":"Bone Res"},{"key":"R19-20250819","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.835720","article-title":"Bad to the bone: the effects of therapeutic glucocorticoids on osteoblasts and osteocytes","volume":"13","author":"Gado","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R20-20250819","doi-asserted-by":"crossref","DOI":"10.1016\/j.cytogfr.2023.03.002","article-title":"Pathogenic mechanisms of glucocorticoid-induced osteoporosis","volume":"70","author":"Chen","year":"2023","journal-title":"Cytokine Growth Factor Rev"},{"key":"R21-20250819","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s40267-024-01079-4","article-title":"Glucocorticoid-induced osteoporosis\u2014from molecular mechanism to clinical practice","volume":"40","author":"Hsu","year":"2024","journal-title":"Drugs Ther Perspect"},{"key":"R22-20250819","doi-asserted-by":"crossref","first-page":"733611","DOI":"10.3389\/fendo.2021.733611","article-title":"Endogenous glucocorticoid metabolism in bone: friend or foe","volume":"12","author":"Martin","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R23-20250819","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.biomaterials.2008.09.047","article-title":"Improved tissue-engineered bone regeneration by endothelial cell mediated vascularization","volume":"30","author":"Yu","year":"2009","journal-title":"Biomaterials"},{"key":"R24-20250819","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.injury.2011.03.035","article-title":"Angiogenesis in bone regeneration","volume":"42","author":"Hankenson","year":"2011","journal-title":"Injury"},{"key":"R25-20250819","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1210\/endo.141.5.7458","article-title":"Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation","volume":"141","author":"Deckers","year":"2000","journal-title":"Endocrinology"},{"key":"R26-20250819","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1172\/JCI15153","article-title":"Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4","volume":"110","author":"Peng","year":"2002","journal-title":"J Clin Invest"},{"key":"R27-20250819","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/1535370214553906","article-title":"The effect of deferoxamine on angiogenesis and bone repair in steroid-induced osteonecrosis of rabbit femoral heads","volume":"240","author":"Li","year":"2015","journal-title":"Exp Biol Med"},{"key":"R28-20250819","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.cytogfr.2013.03.008","article-title":"Angiogenic factors in bone local environment","volume":"24","author":"Chim","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"key":"R29-20250819","doi-asserted-by":"crossref","first-page":"13601","DOI":"10.1038\/ncomms13601","article-title":"Blood flow controls bone vascular function and osteogenesis","volume":"7","author":"Ramasamy","year":"2016","journal-title":"Nat Commun"},{"key":"R30-20250819","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1474-9726.2009.00545.x","article-title":"Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice","volume":"9","author":"Weinstein","year":"2010","journal-title":"Aging Cell"},{"key":"R31-20250819","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12891-020-03225-1","article-title":"Decreased angiogenic and increased apoptotic activities of bone microvascular endothelial cells in patients with glucocorticoid-induced osteonecrosis of the femoral head","volume":"21","author":"Huachen","year":"2020","journal-title":"BMC Musculoskelet Disord"},{"key":"R32-20250819","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.bone.2003.08.002","article-title":"The role of vascular endothelial growth factor in glucocorticoid-induced bone loss: evaluation in a minipig model","volume":"33","author":"Pufe","year":"2003","journal-title":"Bone"},{"key":"R33-20250819","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/nm.3668","article-title":"PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis","volume":"20","author":"Xie","year":"2014","journal-title":"Nat Med"},{"key":"R34-20250819","doi-asserted-by":"crossref","first-page":"426","DOI":"10.7150\/thno.34126","article-title":"Type H blood vessels in bone modeling and remodeling","volume":"10","author":"Peng","year":"2020","journal-title":"Theranostics"},{"key":"R35-20250819","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nature13145","article-title":"Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone","volume":"507","author":"Kusumbe","year":"2014","journal-title":"Nature"},{"key":"R36-20250819","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1002\/jbmr.4171","article-title":"Bone vasculature and bone marrow vascular niches in health and disease","volume":"35","author":"Chen","year":"2020","journal-title":"J Bone Miner Res"},{"key":"R37-20250819","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ecl.2012.04.004","article-title":"Glucocorticoid-induced osteoporosis and osteonecrosis","volume":"41","author":"Weinstein","year":"2012","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R38-20250819","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12020-011-9580-0","article-title":"Glucocorticoid-induced osteonecrosis","volume":"41","author":"Weinstein","year":"2012","journal-title":"Endocrine"},{"key":"R39-20250819","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3109\/10520295.2016.1161234","article-title":"Glucocorticoid effects on angiogenesis are associated with mTOR pathway activity","volume":"91","author":"Ozmen","year":"2016","journal-title":"Biotech Histochem"},{"key":"R40-20250819","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ncprheum0898","article-title":"Genomic and nongenomic effects of glucocorticoids","volume":"4","author":"Stahn","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"key":"R41-20250819","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2174\/138945010791011938","article-title":"NF-kappa B signaling: multiple angles to target OA","volume":"11","author":"Marcu","year":"2010","journal-title":"Curr Drug Targets"},{"key":"R42-20250819","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10456-008-9094-4","article-title":"NF-kappa B: a new player in angiostatic therapy","volume":"11","author":"Tabruyn","year":"2008","journal-title":"Angiogenesis"},{"key":"R43-20250819","first-page":"2786","article-title":"Nuclear factor-kappa B mediates angiogenesis and metastasis of human bladder cancer through the regulation of interleukin-8","volume":"9","author":"Karashima","year":"2003","journal-title":"Clin Cancer Res"},{"key":"R44-20250819","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1182\/blood-2009-07-232132","article-title":"NF-kappa B balances vascular regression and angiogenesis via chromatin remodeling and NFAT displacement","volume":"116","author":"Aurora","year":"2010","journal-title":"Blood"},{"key":"R45-20250819","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/jbmr.3987","article-title":"Glucocorticoids disrupt skeletal angiogenesis through transrepression of NF-kappaB-mediated preosteoclast Pdgfb transcription in young mice","volume":"35","author":"Peng","year":"2020","journal-title":"J Bone Miner Res"},{"key":"R46-20250819","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/nm1197-1285","article-title":"Osteopetrosis in mice lacking NF-kappa B1 and NF-kappa B2","volume":"3","author":"Iotsova","year":"1997","journal-title":"Nat Med"},{"key":"R47-20250819","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1101\/gad.11.24.3482","article-title":"Requirement for NF-kappa B in osteoclast and B-cell development","volume":"11","author":"Franzoso","year":"1997","journal-title":"Genes Dev"},{"key":"R48-20250819","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1002\/jbmr.4015","article-title":"Ubiquitin-specific protease 34 inhibits osteoclast differentiation by regulatingNF-kappa B Signaling","volume":"35","author":"Li","year":"2020","journal-title":"J Bone Miner Res"},{"key":"R49-20250819","doi-asserted-by":"crossref","first-page":"11928","DOI":"10.1038\/s41598-017-12196-8","article-title":"Excessive activation of TLR4\/NF-kappa B interactively suppresses the canonical Wnt\/beta-catenin pathway and induces SANFH in SD rats","volume":"7","author":"Pei","year":"2017","journal-title":"Sci Rep"},{"key":"R50-20250819","doi-asserted-by":"crossref","first-page":"112323","DOI":"10.1016\/j.intimp.2024.112323","article-title":"The hidden dangers of short-term glucocorticoid use in children: a genomic analysis","volume":"135","author":"Xu","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"R51-20250819","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/FPC.0b013e3283385a1c","article-title":"Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein)","volume":"21","author":"Hodges","year":"2011","journal-title":"Pharmacogenet Genomics"},{"key":"R52-20250819","doi-asserted-by":"crossref","first-page":"e18636","DOI":"10.7717\/peerj.18636","article-title":"CYP3A4 and CYP3A5: the crucial roles in clinical drug metabolism and the significant implications of genetic polymorphisms","volume":"12","author":"Zhang","year":"2024","journal-title":"PeerJ"},{"key":"R53-20250819","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/hmg\/ddad173","article-title":"Comparison of pharmaceutical properties and biological activities of prednisolone, deflazacort, and vamorolone in DMD disease models","volume":"33","author":"Liu","year":"2024","journal-title":"Hum Mol Genet"},{"key":"R54-20250819","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.44178","article-title":"Efficacy and safety of vamorolone in duchenne muscular dystrophy: a 30-month nonrandomized controlled open-label extension trial","volume":"5","author":"Mah","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R55-20250819","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.bone.2009.06.030","article-title":"Glucocorticoids, osteocytes, and skeletal fragility: the role of bone vascularity","volume":"46","author":"Weinstein","year":"2010","journal-title":"Bone"},{"key":"R56-20250819","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/315850","article-title":"Tetramethylpyrazine enhances vascularization and prevents osteonecrosis in steroid-treated rats","volume":"2015","author":"Jiang","year":"2015","journal-title":"Biomed Res Int"},{"key":"R57-20250819","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1177\/147323001003800333","article-title":"Changes in femoral head blood supply and vascular endothelial growth factor in rabbits with steroid-induced osteonecrosis","volume":"38","author":"Wang","year":"2010","journal-title":"J Int Med Res"},{"key":"R58-20250819","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034647","article-title":"Salvianolic acid b prevents bone loss in prednisone-treated rats through stimulation of osteogenesis and bone marrow angiogenesis","volume":"7","author":"Cui","year":"2012","journal-title":"PLoS One"},{"key":"R59-20250819","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1172\/JCI31581","article-title":"The hypoxia-inducible factor \u03b1 pathway couples angiogenesis to osteogenesis during skeletal development","volume":"117","author":"Wang","year":"2007","journal-title":"J Clin Invest"},{"key":"R60-20250819","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1210\/en.2017-00662","article-title":"The pathophysiological sequence of glucocorticoid-induced osteonecrosis of the femoral head in male mice","volume":"158","author":"Weinstein","year":"2017","journal-title":"Endocrinology"},{"key":"R61-20250819","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00223-016-0195-6","article-title":"A novel hybrid compound LLP2A-Ale both prevented and rescued the osteoporotic phenotype in a mouse model of glucocorticoid-induced osteoporosis","volume":"100","author":"Mohan","year":"2017","journal-title":"Calcif Tissue Int"},{"key":"R62-20250819","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1210\/jc.2008-1879","article-title":"Cortisol inactivation by 11\u03b2-hydroxysteroid dehydrogenase-2 may enhance endometrial angiogenesis via reduced thrombospondin-1 in heavy menstruation","volume":"94","author":"Rae","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R63-20250819","first-page":"zjaf041","article-title":"Circulating CD34-positive cells are associated with prolonged time to fracture in people with Duchenne muscular dystrophy on chronic glucocorticoids","author":"Sadlowski","year":"2025","journal-title":"J Bone Miner Res"},{"key":"R64-20250819","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1210\/er.2018-00097","article-title":"Glucocorticoids and bone: consequences of endogenous and exogenous excess and replacement therapy","volume":"39","author":"Hardy","year":"2018","journal-title":"Endocr Rev"},{"key":"R65-20250819","first-page":"369","article-title":"Bioactive peptide relieves glucocorticoid-induced osteoporosis by giant macrocyclic encapsulation","author":"Shang","year":"2024","journal-title":"J Controlled Release"},{"key":"R66-20250819","article-title":"Gli1+ progenitors mediate glucocorticoid-induced osteoporosis in vivo","volume":"25","author":"Yang","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R67-20250819","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1093\/ndt\/gfr212","article-title":"Steroid-related osteonecrosis-an update","volume":"26","author":"Drescher","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R68-20250819","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3109\/17453674.2014.960997","article-title":"iNOS expression and osteocyte apoptosis in idiopathic, nontraumatic osteonecrosis","volume":"86","author":"Wang","year":"2015","journal-title":"Acta Orthop"},{"key":"R69-20250819","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1016\/j.lfs.2004.04.048","article-title":"Fas\/CD95 is associated with glucocorticoid-induced osteocyte apoptosis","volume":"75","author":"Kogianni","year":"2004","journal-title":"Life Sci"},{"key":"R70-20250819","doi-asserted-by":"crossref","first-page":"e46625","DOI":"10.1371\/journal.pone.0046625","article-title":"Inhibition of proliferation, migration and proteolysis contribute to corticosterone-mediated inhibition of angiogenesis","volume":"7","author":"Shikatani","year":"2012","journal-title":"PLoS One"},{"key":"R71-20250819","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: mechanism of action and role in clinical practice","volume":"83","author":"Drake","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"R72-20250819","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/jbmr.3728","article-title":"Parathyroid hormone remodels bone transitional vessels and the leptin receptor-positive pericyte network in mice","volume":"34","author":"Caire","year":"2019","journal-title":"J Bone Miner Res"},{"key":"R73-20250819","doi-asserted-by":"crossref","first-page":"e18569","DOI":"10.1111\/jcmm.18569","article-title":"Functions of Epimedin C in a zebrafish model of glucocorticoid-induced osteoporosis","volume":"28","author":"Zhou","year":"2024","journal-title":"J Cell Mol Med"},{"key":"R74-20250819","article-title":"Lactobacillus plantarum attenuates glucocorticoid-induced osteoporosis by altering the composition of rat gut microbiota and serum metabolic profile","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"key":"R75-20250819","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1002\/ptr.8310","article-title":"Delay the progression of glucocorticoid-induced osteoporosis: Fraxin targets ferroptosis via the Nrf2\/GPX4 pathway","volume":"38","author":"Zheng","year":"2024","journal-title":"Phytother Res"},{"key":"R76-20250819","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1080\/13880209.2023.2173787","article-title":"Morroniside ameliorates glucocorticoid-induced osteoporosis and promotes osteoblastogenesis by interacting with sodium-glucose cotransporter 2","volume":"61","author":"Yang","year":"2023","journal-title":"Pharm Biol"},{"key":"R77-20250819","article-title":"Angiogenesis as a novel therapeutic strategy for Duchenne muscular dystrophy through decreased ischemia and increased satellite cells","volume":"53","author":"Shimizu-Motohashi","year":"2014","journal-title":"Front Physiol"},{"key":"R78-20250819","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252111824","article-title":"Angiopoietin 1 attenuates dysregulated angiogenesis in the gastrocnemius of DMD Mice","volume":"25","author":"McClennan","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R79-20250819","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3389\/fimmu.2020.00937","article-title":"Transcriptional regulation of osteoclastogenesis: the emerging role of KLF2","volume":"11","author":"Rolph","year":"2020","journal-title":"Front Immunol"},{"key":"R80-20250819","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/ar2298","article-title":"NF-kappa B inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor","volume":"9","author":"Kubota","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"R81-20250819","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1007\/s00198-013-2313-x","article-title":"NF-kappa B signaling and bone resorption","volume":"24","author":"Abu-Amer","year":"2013","journal-title":"Osteopor Int"},{"key":"R82-20250819","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1084\/jem.20051150","article-title":"Autoamplification of NFATc1 expression determines its essential role in bone homeostasis","volume":"202","author":"Asagiri","year":"2005","journal-title":"J Exp Med"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001476","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T18:00:55Z","timestamp":1755626455000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":82,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000001476","relation":{},"ISSN":["1531-698X"],"issn-type":[{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]}}}